Medial Ag

What Medial Ag does

Medial AG is a privately held Swiss pharmaceutical services provider headquartered in Allschwil/Basel, with over 40 years of operating history across CIS/Central Asia (including Mongolia), Sub-Sahara Africa, and European markets. The company functions as an end-to-end commercialization intermediary between pharmaceutical and biotechnology manufacturers/trademark owners and the downstream market — patients, doctors, healthcare organizations, and importers. Its service portfolio spans five integrated lines: (1) Registration Services, covering regulatory dossier validation, listing/reimbursement consultation, and submission follow-up with governmental authorities; (2) Marketing & Promotion Services, including market analysis, sales force sizing, medical representative training, and continuing medical education via round-tables, seminars, and conferences; (3) Distribution & Logistics Services, anchored by a headquarters warehouse with bonded warehouse authorization, cold storage, psychotropic product storage, batch traceability, and multi-modal transportation (road/air/sea); (4) Licensing & Development Services, structured around co-development, co-marketing, and in-licensing agreements for ethical pharmaceuticals, OTC products, and medical devices; and (5) Pre-Wholesale Services offering one-stop-shop solutions for the full distribution cycle in Swiss and European markets.

The underlying technology is conventional pharmaceutical logistics infrastructure rather than a software platform. Core capabilities include a Supply and Warehouse Management System with rolling forecasts and batch-level traceability for medicaments, bonded warehouse authorization for receipt and distribution without import barriers, and specialized cold chain and controlled-substance storage. Distribution is supported by a transportation department dispatching across road, air, and sea, and by consignment-based and repackaging options for local market adaptation. Customer segments are described at category level — pharmaceutical companies (primary), biotechnology companies, government health organizations participating in tender markets, and pharmaceutical importers — with no named logos or revenue split disclosed.

The business model combines professional services fees (registration, marketing/promotion), managed services (distribution, pre-wholesale), and licensing/royalty arrangements (co-development, in-licensing). Pricing is contract-based and not publicly disclosed. The go-to-market is enterprise field sales with local teams in each target geography conducting sales force management, medical representative training, market segmentation, and key opinion leader targeting. No revenue, headcount, funding rounds, M&A activity, or ownership details beyond a generic Owners / Board of Directors / Management governance structure are disclosed, limiting visibility into the company's scale and growth dynamics.

Name

Medial Ag

Legal name

Medial AG

Website

https://medial-ag.swiss

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Medial AG is a Swiss pharmaceutical services provider offering registration, marketing and promotion, distribution and logistics, licensing, and pre-wholesale services to pharmaceutical and biotechnology manufacturers seeking market entry across CIS/Central Asia, Sub-Sahara Africa, and European markets.

Ownership category

akta.pro rank

Product category

Pharmaceutical Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro industry

PRIMARYHLAIAJAB

Specialty Pharmaceutical Distributors

Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling

SECONDARYTLAIACAD

Pharmaceutical & Life Sciences Warehousing (GDP-Compliant)

Transportation & Logistics/Third-Party & Fourth-Party Logistics (3PL/4PL) / Contract Logistics/Warehousing Operations & Contract Storage (Dedicated/Shared)

SECONDARYHLAGAKAO

Third-Party/Outsourced Quality & Responsible Person Services (EU QP/RP, US Agent)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

SECONDARYTLALABAH

Medical Devices & Diagnostics Temperature-Controlled Storage

Transportation & Logistics/Warehousing & Storage (Cold Chain, Fulfillment, Depots)/Cold Chain Warehousing & Refrigerated Storage

Keywords

• Pharmaceutical distribution services
• Regulatory registration services
• Pharmaceutical marketing services
• Pharma licensing and development
• Pharmaceutical logistics services

Headquarters

HQ city

Allschwil

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure, Supply Chain, Others

Revenue model

1. Registration Services: Professional registration and regulatory services for pharmaceutical products including dossier validation, regulatory consultation, submission and follow-up with governmental authorities until registration is granted.
2. Marketing & Promotion Services: Marketing campaign design and management, market analysis, sales force sizing, medical representative training, and ongoing marketing activities including continuing medical education via round-tables, seminars and conferences.
3. Distribution & Logistics: Wholesale distribution, pre-wholesale operations, pharmacy delivery, custom-made warehousing and distribution solutions including consignment-based distribution. Additional services such as repackaging to meet local market needs.
4. Licensing & Development: Licensing arrangements including co-development, co-marketing, and in-licensing agreements for distribution in specific geographical areas. Custom-made solutions for partners.
5. Pre-Wholesale Logistics: One-stop shop solutions for the whole distribution cycle in Swiss and European markets.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels3 records

Core offering

Medial AG is a Swiss pharmaceutical services company that acts as the interface between pharmaceutical manufacturers/trademark owners and patients, doctors, healthcare organizations, and importers in CIS/Central Asia, Sub-Sahara Africa, and European countries. It delivers an end-to-end stack of registration, marketing & promotion, distribution & logistics, licensing & development, and pre-wholesale services for ethical pharmaceuticals, OTC products, and medical devices. The company combines a bonded warehouse, cold storage, and field sales teams to take products from regulatory submission through to commercialization.

Product overview

Medial AG is a Swiss pharmaceutical services provider offering a unified suite of integrated services for the pharmaceutical and biotech industry. The core offerings include Registration Services (regulatory procedures and dossier management), Marketing & Promotion Services (campaign design, market analysis, and sales force management), Distribution & Logistics Services (wholesale, pre-wholesale, pharmacy delivery, bonded warehouse, cold storage), Licensing & Development Services (co-development, co-marketing, in-licensing agreements), and Pre-wholesale Logistic Services. These services work together to cover the complete lifecycle from market entry through commercialization in CIS, Sub-Sahara Africa, and European countries.

Differentiator

Problem solved

Functional benefit

Products and services

• Registration Services Regulatory and registration procedures for pharmaceutical products, including pharma dossier validation, consultation on listing and reimbursement, and submission and follow-up with governmental regulatory agencies. Offered to pharmaceutical and biotechnology manufacturers seeking market entry.
• Marketing & Promotion Services Marketing campaigns designed and managed in close collaboration with clients, including market analysis, sales force sizing, medical representative training, target segment identification, and continuing medical education via round-tables, seminars, and conferences.
• Distribution & Logistics Services Wholesale distribution, pre-wholesale, and pharmacy delivery services, including bonded warehouse operations, cold storage facilities, batch traceability of medicaments, and transportation by road, air, or sea.
• Licensing & Development Services Custom-made licensing solutions including co-development, co-marketing, and in-licensing agreements for distribution in specific geographical areas, covering ethical pharmaceuticals, OTC products, and medical devices.
• Pre-Wholesale Logistic Services Logistic services for pre-wholesale and wholesale activities in Swiss and European markets, offering one-stop shop solutions for the whole distribution cycle.

Quantifiable outcome

• Swift registration procedures through established regulatory agency relationships
• +1 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators2 records

Recent moves4 records

Expansion highlights3 records

Broad incumbents

• McKesson: Global pharmaceutical distribution and services giant serving manufacturers, pharmacies and healthcare providers — provides broader-scale pharma distribution and specialty services that overlap with Medial's distribution offering, particularly for cross-border specialty products.
• Cencora (formerly AmerisourceBergen): Global pharmaceutical distribution and solutions provider, parent of World Courier — competes with Medial in specialty pharma distribution and global logistics services with materially greater scale, capital and technology resources.
• PHOENIX Group: European pharmaceutical wholesale leader with strong distribution and pre-wholesale capabilities across the EU — overlaps with Medial's pre-wholesale and European distribution operations but at materially larger scale and broader geographic scope.
• Sinopharm: State-affiliated Chinese pharmaceutical distribution and supply chain group with significant CIS/Central Asia and emerging-market footprint — relevant competitor for cross-border distribution flows into Medial's CIS geographies.

Direct peers

• DKSH Holding: Swiss-headquartered market expansion services group providing pharmaceutical registration, distribution, marketing and licensing across Asia and emerging markets — the closest functional mirror to Medial's bundled pharma market-entry model in CIS and Africa.
• Marken (UPS Healthcare): Global pharma logistics provider with strong emerging-market presence, offering specialty cold-chain distribution and clinical trial supply — comparable to Medial's specialized storage and international distribution capabilities.
• Zuellig Pharma: Asia-Pacific headquartered pharma distribution and services group offering distribution, regulatory, and commercialization support across emerging Asian and African markets — comparable business model with similar geographic focus on harder-to-reach territories.
• Mawdsleys: UK-based specialty pharmaceutical distribution and services company providing market entry, regulatory and supply chain support — similar service bundle to Medial's registration-plus-distribution offering for manufacturers entering new geographies.
• World Courier: Specialty pharmaceutical logistics provider focused on clinical trial and biopharmaceutical cold-chain transportation — directly comparable to Medial's specialty cold-chain and controlled-substance storage capabilities.
• Alloga Europe: European pre-wholesale pharmaceutical logistics provider serving manufacturers across multiple European markets — directly overlaps with Medial's pre-wholesale and wholesale service line for Swiss and European customers.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/medial-ag-swiss

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medial Ag